XML 62 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727
Derivative Financial Instruments
3 Months Ended
Jul. 05, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
The Company is exposed to market risks arising from adverse changes in commodity prices affecting the cost of raw materials and energy, interest rates and foreign exchange risks. In the normal course of business, these risks are managed through a variety of strategies, including the use of derivative instruments. Commodity forward contracts are periodically used to hedge forecasted purchases of certain commodities, foreign currency exchange contracts are used to hedge forecasted transactions denominated in a foreign currency, and the Company periodically uses interest rate swaps to hedge forecasted interest payments and the risk associated with variable interest rates on long-term debt.
The Company's copper and zinc forward contracts essentially establish a fixed price for the underlying commodity and are designated and qualify as effective cash flow hedges of purchases of the commodity. Ineffectiveness is calculated as the amount by which the change in the fair value of the derivatives exceeds the change in the fair value of the anticipated commodity purchases.
The Company entered into interest rate swaps in fiscal 2014 whereby the Company pays a fixed rate on a total notional amount of $400,000 and receives one-month LIBOR. The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. The Company performs assessments of the effectiveness of hedge instruments on a quarterly basis and determined the hedges to be highly effective. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at July 5, 2015, five of the outstanding swap agreements were in a net liability position which would require the Company to make the net settlement payments to the counterparties. The Company does not anticipate nonperformance by the Company's counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.
The Company entered into foreign currency forward contracts during fiscal 2015 to hedge forecasted cash receipts from a customer and forecasted inventory purchases and subsequent payments. These transactions were designated and qualified as effective cash flow hedges.
Ineffectiveness with respect to forecasted inventory purchases or customer cash receipts was calculated based on changes in the forward rate until the anticipated purchase or cash receipt occurs; ineffectiveness of the hedge of the accounts payable was evaluated based on the change in fair value of its anticipated settlement.
The fair value of the commodity and foreign currency forward contracts is recorded within other assets or liabilities, as appropriate, and the effective portion is reflected in accumulated other comprehensive income (loss) in the financial statements. The gains or losses on the commodity forward contracts are recorded in inventory as the commodities are purchased. The gains or losses on the foreign currency forward contracts are recorded in earnings when the related inventory is sold.
As of July 5, 2015, the Company had the following outstanding commodity forward contracts which hedge forecasted purchases:
 
Number of Pounds
Copper
14,000

Zinc
3,200


As of July 5, 2015, the Company had three outstanding interest rate swaps with notional amounts of $100,000 each with maturity dates in August 2016, 2017 and 2018, as well as two interest rate swaps with notional amounts of $50,000 each with maturity dates in November 2016 and 2017. See Note 12 for additional information.
As of July 5, 2015, the Company had the following outstanding foreign currency forward contracts in place:
 
Quantity Hedged
Euros Sold
93,280

Euros Purchased
23,258


The table below presents the fair value and location of the Company's derivative instruments designated as hedging instruments in the consolidated balance sheets as of the periods presented.
 
 
 
 
Asset Derivatives
Fair Value
 
Liability Derivatives
Fair Value
 
 
Location
 
July 5, 2015
 
March 31, 2015
 
July 5, 2015
 
March 31, 2015
Commodity forward contracts
 
Other current assets /
other current liabilities
 
$
14

 
$
1,054

 
$
443

 
$
899

Commodity forward contracts
 
Deferred charges and
other noncurrent assets /
other noncurrent liabilities
 

 
271

 

 
2

Foreign currency forward contracts
 
Other current assets /
other current liabilities
 
1,503

 
2,664

 
3,079

 
5,101

Foreign currency forward contracts
 
Deferred charges and
other noncurrent assets /
other noncurrent liabilities
 
1,613

 
3,834

 
222

 
897

Interest rate contracts
 
Deferred charges and
other noncurrent assets /
other noncurrent liabilities
 

 

 
3,633

 
4,238

Total
 
 
 
$
3,130

 
$
7,823

 
$
7,377

 
$
11,137


Due to the nature of the Company's business, the benefits associated with the commodity contracts may be passed on to the customer and not realized by the Company.
For the periods presented below, the derivative gains and losses in the condensed consolidated statements of comprehensive income related to derivative instruments were as follows:
 
 
Gain (Loss) Reclassified from AOCI
 
Gain (Loss) Recognized in Income
(ineffective portion and amount excluded from effectiveness testing)
 
 
Location
 
Amount
 
Location
 
Amount
Quarter Ended July 5, 2015
 
 
 
 
 
 
 
 
Commodity forward contracts
 
Cost of Sales
 
$
(190
)
 
Cost of Sales
 
$

Interest rate contracts
 
Interest expense
 
(1,020
)
 
Interest expense
 

Foreign currency forward contracts
 
Cost of Sales
 
(557
)
 
Cost of Sales
 

Quarter ended June 29, 2014
 
 
 
 
 
 
 
 
Commodity forward contracts
 
Cost of Sales
 
$
(2,525
)
 
Cost of Sales
 
$

Interest rate contracts
 
Interest expense
 
(1,041
)
 
Interest expense
 

Foreign currency forward contracts
 
Cost of Sales
 

 
Cost of Sales
 


All derivatives used by the Company during the periods presented were designated as hedging instruments for accounting purposes.
The Company expects the remaining unrealized losses will be realized and reported in cost of sales as the cost of the commodities is included in cost of sales. Estimated and actual gains or losses will change as market prices change.